Barclays’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Buy
123,307
+24,282
+25% +$228K ﹤0.01% 2567
2025
Q1
$536K Sell
99,025
-21,196
-18% -$115K ﹤0.01% 2807
2024
Q4
$895K Sell
120,221
-124,824
-51% -$929K ﹤0.01% 2698
2024
Q3
$1.96M Buy
245,045
+197,033
+410% +$1.58M ﹤0.01% 2186
2024
Q2
$418K Sell
48,012
-117,675
-71% -$1.02M ﹤0.01% 2633
2024
Q1
$3.43M Buy
165,687
+6,045
+4% +$125K ﹤0.01% 1570
2023
Q4
$3.69M Buy
159,642
+113,983
+250% +$2.63M ﹤0.01% 1714
2023
Q3
$365K Buy
45,659
+23,208
+103% +$186K ﹤0.01% 2716
2023
Q2
$195K Sell
22,451
-5,523
-20% -$48K ﹤0.01% 3093
2023
Q1
$82K Buy
27,974
+20,969
+299% +$61.5K ﹤0.01% 3626
2022
Q4
$25K Buy
7,005
+5,899
+533% +$21.1K ﹤0.01% 3984
2022
Q3
$9K Sell
1,106
-203
-16% -$1.65K ﹤0.01% 4224
2022
Q2
$10K Sell
1,309
-2,737
-68% -$20.9K ﹤0.01% 4313
2022
Q1
$49K Buy
+4,046
New +$49K ﹤0.01% 4010
2020
Q4
Sell
-20
Closed 3588
2020
Q3
$0 Sell
20
-1,767
-99% ﹤0.01% 3773
2020
Q2
$13K Sell
1,787
-299
-14% -$2.18K ﹤0.01% 3613
2020
Q1
$21K Sell
2,086
-4,220
-67% -$42.5K ﹤0.01% 3370
2019
Q4
$98K Buy
6,306
+3,047
+93% +$47.4K ﹤0.01% 3451
2019
Q3
$59K Sell
3,259
-731
-18% -$13.2K ﹤0.01% 3626
2019
Q2
$65K Sell
3,990
-33,512
-89% -$546K ﹤0.01% 3758
2019
Q1
$671K Buy
37,502
+12,402
+49% +$222K ﹤0.01% 2442
2018
Q4
$474K Buy
+25,100
New +$474K ﹤0.01% 2287
2018
Q3
Sell
-391
Closed -$8K 4348
2018
Q2
$8K Buy
+391
New +$8K ﹤0.01% 3942
2018
Q1
Hold
0
4248
2017
Q3
Sell
-3,319
Closed -$57K 4042
2017
Q2
$57K Buy
+3,319
New +$57K ﹤0.01% 2964
2015
Q4
Sell
-290
Closed -$9K 3351
2015
Q3
$9K Buy
+290
New +$9K ﹤0.01% 3093